We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,245 hedge funds and large institutions have $56.9B invested in Celgene Corp in 2019 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 350 increasing their positions, 572 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 109127 (+18)

12% more capital invested

Capital invested by funds: $51.1B → $56.9B (+$5.88B)

3% less funds holding

Funds holding: 1,2871,245 (-42)

31% less first-time investments, than exits

New positions opened: 73 | Existing positions closed: 106

39% less repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 572

59% less call options, than puts

Call options by funds: $796M | Put options by funds: $1.95B

Holders
1,245
Holders Change
-42
Holders Change %
-3.26%
% of All Funds
27.3%
Holding in Top 10
127
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+16.51%
% of All Funds
2.78%
New
73
Increased
350
Reduced
572
Closed
106
Calls
$796M
Puts
$1.95B
Net Calls
-$1.15B
Net Calls Change
-$98.3M
Name Holding Trade Value Shares
Change
Change in
Stake
First Manhattan
226
First Manhattan
New York
$21.4M -$7.13K -75 -0%
Massachusetts Financial Services
227
Massachusetts Financial Services
Massachusetts
$21.2M -$1.92M -20,192 -9%
PA
228
Profund Advisors
Maryland
$21.1M -$1.04M -10,940 -5%
ZIC
229
ZWJ Investment Counsel
Georgia
$21M -$820K -8,632 -4%
PAG
230
Private Advisor Group
New Jersey
$20.9M +$10.7M +112,640 +130%
PDM
231
Penn Davis McFarland
Texas
$20.9M -$176K -1,849 -0.9%
BCIM
232
British Columbia Investment Management
British Columbia, Canada
$20.8M -$3.86M -40,673 -16%
EAM
233
Erste Asset Management
Austria
$20.8M -$302K -3,180 -1%
SC
234
Saturna Capital
Washington
$20.4M
Axa
235
Axa
France
$20.4M -$40.8M -429,677 -68%
NSLI
236
Nan Shan Life Insurance
Taiwan
$20.2M -$5.84M -61,500 -23%
YCM
237
Yakira Capital Management
Connecticut
$19.9M
FAF
238
Fjarde Ap-fonden
Sweden
$19.6M -$95K -1,000 -0.5%
KC
239
Kellner Capital
New York
$19.5M +$760K +8,000 +4%
APG Asset Management
240
APG Asset Management
Netherlands
$19.4M -$1.42M -14,943 -7%
JMPWA
241
JP Morgan Private Wealth Advisors
California
$19.4M -$319K -3,356 -2%
WAM
242
Weiss Asset Management
Massachusetts
$19.3M +$16.1M +168,918 +676%
MIM
243
MetLife Investment Management
New Jersey
$19.2M -$145K -1,523 -0.8%
KeyBank National Association
244
KeyBank National Association
Ohio
$19.1M -$1.48M -15,588 -8%
MCP
245
Moab Capital Partners
New York
$18.6M +$9.01M +94,780 +102%
CIBC World Market
246
CIBC World Market
Ontario, Canada
$18.5M -$2.11M -22,224 -11%
RSCM
247
Rock Springs Capital Management
Maryland
$18.4M
SAM
248
Silphium Asset Management
United Kingdom
$18.3M
Russell Investments Group
249
Russell Investments Group
United Kingdom
$18.2M -$6.39M -67,226 -27%
Nomura Holdings
250
Nomura Holdings
Japan
$17.9M +$4.83M +50,781 +39%

CELG Hedge Fund Activity: Q3 2019 in Review

1,245 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2019, worth a combined $56.9B — up 12% from $51.1B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of CELG and 73 opened new positions — a net loss of 33 holders — while 572 trimmed existing stakes and 350 added.

The largest buyer was HBK Investments, opening a new position worth an estimated $1.5B. The largest seller was Fidelity Investments, cutting an estimated $377M.

  • 1,245 institutional investors held Celgene Corp (CELG) as of Q3 2019, down from 1,287 in Q2 2019.
  • Funds reported $56.9B of Celgene Corp stock for Q3 2019, up 12% quarter-over-quarter.
  • 73 funds opened new Celgene Corp positions in Q3 2019 and 106 closed out, a net change of -33 holders.
  • The largest Celgene Corp buyer in Q3 2019 was HBK Investments, an estimated $1.5B added.
  • The largest Celgene Corp seller in Q3 2019 was Fidelity Investments, an estimated $377M sold.

Based on aggregated 13F filings for Q3 2019.